BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S financial statements, including revenue, expenses, profit, and loss

The total revenue of BXP for the last quarter is 76.00 M GBP, and it's 3.46% lower compared to the previous quarter. The net income of Q1 25 is 10.90 M GBP.